Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Inflammatory Bowel Diseases

Free Subscription Articles published in Clin Res Hepatol Gastroenterol Retrieve available abstracts of 31 articles: HTML format

Single Articles

March 2024
1. YANG J, Huang MMC, Liang MMJ, Lei MMY, et al
   The diagnostic performance of serum alphavbeta6 autoantibodies for ulcerative colitis: A systematic review and meta-analysis.
   Clin Res Hepatol Gastroenterol. 2024;48:102317.
   PubMed     Abstract available
   
   
   December 2023
2. GRELLIER N, Sokol H, Seksik P
   Gut dysbiosis in Crohn's disease: never so close to solving the chicken-and-egg enigma: Commentary to "Gut Microbiome Composition Is Associated with Future Onset of Crohn's Disease in Healthy First-Degree Relatives, by Raygoza Garay JA et al., Gastroe
   Clin Res Hepatol Gastroenterol. 2023 Dec 23:102272.
   PubMed     Abstract available
   
   
   November 2023
3. KAKDIYA R, Jha DK, Choudhury A, Jena A, et al
   Indigo naturalis (Qing dai) for inflammatory bowel disease: A systematic review and meta-analysis.
   Clin Res Hepatol Gastroenterol. 2023 Nov 23:102250.
   PubMed     Abstract available
   
   
   
4. UZZAN M, Assouline V, Chambenois E, Djabbari M, et al
   Focal loss of mural stratification as a radiological predictor for small bowel adenocarcinoma in Crohn's disease.
   Clin Res Hepatol Gastroenterol. 2023 Nov 13:102246.
   PubMed     Abstract available
   
   
   September 2023
5. ZHANG C, Liu X
   Fundamental crosstalk between circadian rhythm and the intestine in the pathogenesis of inflammatory bowel disease.
   Clin Res Hepatol Gastroenterol. 2023;47:102214.
   PubMed     Abstract available
   
   
   June 2023
6. JENA A, Neelam PB, Telaprolu H, Mangipudi UK, et al
   Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression.
   Clin Res Hepatol Gastroenterol. 2023 Jun 8:102155.
   PubMed     Abstract available
   
   
   April 2023
7. DAR SH, Maniya MT, Merza N, Musheer A, et al
   The Association of Antibiotic Exposure with New-Onset Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
   Clin Res Hepatol Gastroenterol. 2023 Apr 26:102129.
   PubMed     Abstract available
   
   
   March 2023
8. DE PARADES V, Fathallah N, Peyrin-Biroulet L
   The case for the prevention of fistulas in patients with perianal Crohn's disease.
   Clin Res Hepatol Gastroenterol. 2023 Mar 21:102113.
   PubMed    
   
   
   
9. BOZON A, Nancey S, Serrero M, Caillo L, et al
   Risk of Infection in Elderly Patients with Inflammatory Bowel Disease under biologics: A Prospective, Multicenter, Observational, One-Year follow-up comparative study.
   Clin Res Hepatol Gastroenterol. 2023 Mar 9:102107.
   PubMed     Abstract available
   
   
   February 2023
10. ZHANG L, Hu C, Zhang Z, Liu R, et al
    Association Between Prior Appendectomy and The Risk and Course of Crohn's Disease: A Systematic Review and Meta-analysis.
    Clin Res Hepatol Gastroenterol. 2023 Feb 4:102090.
    PubMed     Abstract available
    
    
    January 2023
11. CHEN LT, Zhang JY, Zheng JW, Yu J, et al
    The detection rate of granulomas differs between intestinal segments and lesions in Chinese patients with Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2023;47:102076.
    PubMed     Abstract available
    
    
    November 2022
12. PENG C, Zheng C, Xie Y, Sun Q, et al
    Granulomatosis with Polyangiitis with colon involvement as a mimicker of Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2022;47:102057.
    PubMed    
    
    
    
13. FAVAREL-GARRIGUES M, Cadiot G, Bermejo M, Boulagnon-Rombi C, et al
    Aseptic splenic abscesses as the inaugural manifestation of Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101989.
    PubMed    
    
    
    
14. RABILLOUD ML, Bajeux E, Siproudhis L, Hamonic S, et al
    Long-term outcomes and predictors of disabling disease in a population-based cohort of patients with incident Crohn's disease diagnosed between 1994 and 1997.
    Clin Res Hepatol Gastroenterol. 2022;46:101974.
    PubMed     Abstract available
    
    
    October 2022
15. GONZALEZ-MORCILLO G, Calderon-Hernanz B, Serrano-Lopez de Las Hazas J, de Hita-Santabaya AI, et al
    Ribavirin-resistant chronic norovirus infection-associated enteropathy in common variable immunodeficiency. Case report and review of the literature.
    Clin Res Hepatol Gastroenterol. 2022;46:101956.
    PubMed     Abstract available
    
    
    
16. VEISMAN I, Lederer NB, Ukashi O, Kopylov U, et al
    Top 25 cited articles on Covid-19 and IBD: A bibliometric analysis.
    Clin Res Hepatol Gastroenterol. 2022;46:101959.
    PubMed     Abstract available
    
    
    August 2022
17. GOETGEBUER RL, Masclee GMC, van der Eijk AA, van der Woude CJ, et al
    Hepatitis E infection with a benign course during vedolizumab treatment for Crohn's disease: A case report.
    Clin Res Hepatol Gastroenterol. 2022;46:101948.
    PubMed     Abstract available
    
    
    June 2022
18. NAYAGAM JS, Mandour MO, Taylor A, Heneghan MA, et al
    Clinical course of inflammatory bowel disease and impact on liver disease outcomes in patients with autoimmune sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2022 Jun 18:101980.
    PubMed     Abstract available
    
    
    April 2022
19. YZET C, Brazier F, Sebbagh V, Vanelslander P, et al
    Complete endoscopic healing is associated with lower disability than partial endoscopic healing in Crohn's disease: A prospective multicenter study.
    Clin Res Hepatol Gastroenterol. 2022;46:101887.
    PubMed     Abstract available
    
    
    
20. HE C, Li H, Zhou P, Zhang W, et al
    A novel XIAP mutation in an adult Chinese patient with refractory Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101845.
    PubMed    
    
    
    February 2022
21. XIA H, Li S, He Y, Ren Q, et al
    Long non-coding RNA ANRIL serves as a potential marker of disease risk, inflammation, and disease activity of pediatric inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2022 Feb 25:101895.
    PubMed     Abstract available
    
    
    January 2022
22. CHAZOUILLERES O, Potier P, Bouzbib C, Hanslik B, et al
    Non-invasive diagnosis and follow-up of primary sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101775.
    PubMed     Abstract available
    
    
    September 2021
23. FUENTES-VALENZUELA E, Navarro Canadas C, Oyarzun Bahamonde E, Moreta Rodriguez M, et al
    Severe sarcoidosis-like reaction in a patient with Crohn's Disease treated with infliximab. Any relationship?
    Clin Res Hepatol Gastroenterol. 2021;45:101696.
    PubMed    
    
    
    
24. TILMANT M, Serrero M, Poullenot F, Bouguen G, et al
    Endoscopic balloon dilation of colorectal strictures complicating Crohn's disease: a multicenter study.
    Clin Res Hepatol Gastroenterol. 2021;45:101561.
    PubMed     Abstract available
    
    
    
25. RIAULT C, Diouf M, Chatelain D, Yzet C, et al
    Positive histologic margins is a risk factor of recurrence after ileocaecal resection in Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2021;45:101569.
    PubMed     Abstract available
    
    
    
26. TER AVEST MM, van Hee K, Bronkhorst C, de Jonge HJM, et al
    Mesalazine induced autoimmune hepatitis in a patient with Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2021;45:101551.
    PubMed    
    
    
    July 2021
27. LUCOTTI P, Lovati E, Lenti MV, Valvo B, et al
    Abnormal post-prandial glucagon-like peptide release in patients with Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2021;45:101533.
    PubMed     Abstract available
    
    
    March 2021
28. TEMTEM T, Whitworth J, Zhang J, Bagga B, et al
    Cytomegalovirus in pediatric inflammatory bowel disease patients with acute severe colitis.
    Clin Res Hepatol Gastroenterol. 2021;45:101625.
    PubMed     Abstract available
    
    
    
29. BUFFET-BATAILLON S, Landreau C, Siproudhis L, Cattoir V, et al
    Bacterial gut dysbiosis is associated with Crohn's disease symptoms but not with elevated fecal calprotectin.
    Clin Res Hepatol Gastroenterol. 2021;45:101669.
    PubMed    
    
    
    October 2020
30. MASNADI SHIRAZI K, Sotoudeh S, Masnadi Shirazi A, Moaddab SY, et al
    Effect of N-acetylcysteine on remission maintenance in patients with ulcerative colitis: A randomized, double-blind controlled clinical trial.
    Clin Res Hepatol Gastroenterol. 2020 Oct 14. pii: S2210-7401(20)30270.
    PubMed     Abstract available
    
    
    
31. WANG HG, Xie R, Ma TH, Yang XZ, et al
    Excessive anxiety in IBD patients is unnecessary for COVID-19.
    Clin Res Hepatol Gastroenterol. 2020;44:e121-e122.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.